Further, transforming growth factor-β (TGF-β) is a potent stimulator that drives fibrosis, and the downregulation of TGF-β has been found to significantly limit the fibrotic process in chronic kidney disease [27,28,29]. Here, TGFB1 is linked to chronic kidney disease.